Every virus is a parasite. They exist by themselves. He is envious of your wearer. This is the basiccondition of its existence. What living cell carries viruses? Based on work with bovine leukosisvirus (BLV) in the stables, we monitored the course of infection in healthy animals and concludedthat a bacterial cell can be the host …
Nowadays between 30% and 50% of patients with liver cirrhosis die due to bacterial infections [1, 2]. Spontaneous Bacterial Peritonitis (SBP) is a big complication of the severe complication “ascites” in liver cirrhosis [3-5]. SBP is the main cause of death in patients with cirrhosis [2, 6]. SBP does not arisefrom intraabdominal source which requiressurgery …
Metamorphosis (Transfiguration) of Spontaneous Bacterial Peritonitis Read More »
The Pancreatic Adenocarcinoma (PA) is estimated to become the second leading cancer-related death cause by 2030. At the time of diagnosis, 30% of patients have a locally advanced disease especially vascular involvement Performed firstly in 1973; the benefits of vein resection on survival have been clearly demonstrated by published reports
Chromoendoscopic technique dates to 1970, when various dyes were used on the tissue lining the GI tract to detect subtle lesions that are hard to detect using normal endoscopic imaging. Applied colour enhances tissue characterisation thus providing easier identification of pathological con- dition
To investigate the relationship between systemic inflammatory response syndrome (SIRS) and the severity of acute pancreatitis with high altitude polycythemia (hereinafter referred to as AP+HAPC) in individuals living in a high-altitude region, to provide evidence for the treatment of SIRS and AP+HAPC
Inflammatory Bowel Disease (IBD) are the manifestation of overzealous dysregulated immune response in the intestinal tract, directed primarily against the indigenous microbes combined with defective functioning of anti-inflammatory pathways. Finding a trustable lead to predicting de novo Crohn’s Disease (CD)
Inflammatory Bowel Disease (IBD) is recklessly evolving worldwide as incautious disaster, especially in developing nations as a regional duplicitous emergence disease. It has come to light that adaptive Western culture, rapid urbanization lifestyle in the developing nations have been seen
All HIV/HBV co-infected patients in Serbia have been treated with HAART containing an anti- HBV drug, irrespective of CD4 cell count and HBV disease status in order to prevent more active liver disease. Like in many developing countries, lamivudine containing HAART was used in all HBV/HIV co-infected individuals
Surgery for pain in the right lower quadrant of the abdomen remains a clinical dilemma. Right iliac fossa pain is one of the most common causes of abdominal pain in young adults and children in the UK.Acute appendicitis is conventionally a clinical diagnosis; typical symptoms and laboratory
Despite the euphoria about the introduction of a novel and apparently successful treatment in gastroparesis, the amount of high quality data supporting the clinical utility of G-POEM are limited. Above all, the selection of patients with gastroparesis for G-POEM is problematic
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.